Company Filing History:
Years Active: 2020-2024
Title: Innovations by Inventor Nate Larson
Introduction
Nate Larson is an accomplished inventor based in Saint George, Utah, known for his significant contributions to the field of pharmaceuticals. With a total of six patents to his name, Larson aims to enhance treatments for viral infections through novel compounds and formulations.
Latest Patents
Larson's latest patents showcase his innovative approach to combating viral infections. One notable patent is for the crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate. This invention focuses on novel salts and crystalline forms intended for treating viral infections caused by various viruses, including those from the Arenaviridae, Coronaviridae, Filoviridae, Flaviviridae, and Paramyxoviridae families. Another recent patent involves compositions that consist of an RNA polymerase inhibitor and cyclodextrin for treating viral infections, which highlights the importance of innovative chemical combinations in pharmaceutical developments.
Career Highlights
Nate Larson contributes his expertise as part of Gilead Sciences, Inc., a leading company in the biopharmaceutical sector. His work is pivotal in advancing therapeutic options that address complex viral infections. His patents demonstrate a strong focus on chemical innovation and its application in medicine, paving the way for improved treatment modalities.
Collaborations
Throughout his career, Larson has collaborated with talented individuals, including Katrien Brak and Ernest A Carra. These partnerships enhance the creative process and contribute to a collaborative environment aimed at addressing critical health challenges through innovative solutions.
Conclusion
Nate Larson embodies the spirit of innovation in pharmaceuticals. His current research and patents play a crucial role in developing effective treatments for viral infections. By working with Gilead Sciences and collaborating with fellow experts, Larson continues to make impactful contributions to medical science.